Skip to main content

Azenta, Inc.

corporate_fare Company Profile

Azenta, Inc.

AZTA·NASDAQ·Technology·CIK 0000933974

Azenta, Inc. is a leading global provider of biological and chemical compound sample exploration and management solutions for the life sciences industry. The company entered the life sciences market in 2011, leveraging in-house precision automation and cryogenics capabilities previously applied in semiconductor manufacturing, which led to the development of automated ultra-cold storage solutions. Since then, Azenta has expanded its life sciences offerings through internal investments and a series of acquisitions. Azenta supports customers from research and clinical development to commercialization with sample management and automated storage systems, as well as genomic services expertise. Its portfolio spans the life cycle of samples, including procurement, automated storage systems, genomic services, sample consumables, informatics and data software, and sample repository services. Customers include pharmaceutical, biotechnology and life sciences research institutions. As of September 30, 2026, Azenta employed approximately 2,850 full-time employees, part-time employees and contingent workers worldwide and had sales in approximately 87 countries. The company is headquartered in Burlington, Massachusetts, with operations in North America, Asia and Europe. Azenta was founded in 1978 and became a leading automation provider and partner to the global semiconductor manufacturing industry. It divested the last of its semiconductor businesses in February 2022 for $2.9 billion in cash and since then has operated solely as a life sciences company. On December 1, 2021, the company changed its corporate name from "Brooks Automation, Inc." to "Azenta, Inc." and its common stock began trading on the Nasdaq Global Select Market under the symbol "AZTA." In July 2026, Azenta divested its B Medical Systems business for $63.0 million in cash, simplifying its portfolio and allowing management to focus on driving revenue growth and profitability in its core Sample Management Solutions and Multiomics segments.

Azenta, Inc. (NASDAQ:AZTA) is a publicly traded company in the Technology sector. Wiseek has independently scored 23 items for AZTA at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-19, rated 8/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 12 rated 8 or above. Recent SEC coverage for AZTA spans 10-K, 8-K, 10-Q.

Recent high-impact activity:

  • Azenta 10-K: $149M Goodwill Impairment, Adverse ICFR Opinion, $167M Net Loss
  • Azenta Q4 Adjusted EPS of 28 Cents Nearly Triples the 11-Cent Consensus
  • Azenta Guides FY27 Revenue to $648-$660M as Organic Growth Stalls at 2%
  • Azenta Licenses Elegen Gene Synthesis Tech and Buys SynPlexity for GENEWIZ
  • Azenta Restructures Multiomics Segment, Closing Three Labs and Cutting Workforce

Financial Snapshot

Fiscal year ended September 30, 2026
Revenue
$621.7M
Net Income
-$166.99M
Diluted EPS
-$3.70
Op. Cash Flow
$57.51M
Free Cash Flow
$27.43M
Gross Profit
$274.96M
Operating Income
-$174.7M
Cash & Equivalents
$193.8M
Debt / Equity
0.00×
Net Margin
-26.9%
Shares Outstanding
41.76M sh
Source: 10-K · filed 2026-11-19 · accession 0001628280-26-075072

Short Interest & Short Volume

6.20 days to cover

FINRA reported short interest of 5,404,752 shares in AZTA as of the October 30, 2026 settlement, a 0.8% increase from the prior period — about 6.2 days to cover at its recent average daily volume. On November 20, 2026, 58.4% of AZTA volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)5,404,752 shares as of October 30, 2026
Change vs prior period▲ 0.8%
Days to cover6.20 at avg daily volume of 872,402
Daily short volume (FINRA facilities)58.4% of 186,626 shares on November 20, 2026
5-day average short volume49.8%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with A →
$44.8
52-week range · as of 2026-11-19 $15.93 – $50.05
Market cap
$1.88B
Volume
621.1K (0.6× avg)
3-mo avg 995.8K
Live data · 2026-11-21 18:54 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed AZTA - Latest Insights

AZTA
Nov 19, 2026, 4:06 PM EST
Filing Type: 10-K
Importance Score:
8
Price at Filing: $47.09
Real-time Price: $44.80 info
Change: -$2.29 (-5%) info
Market Cap: $1.879B info
AZTA
Nov 10, 2026, 5:44 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $44.20
Real-time Price: $44.80 info
Change: +$0.600 (+1%) info
Market Cap: $1.879B info
AZTA
Nov 10, 2026, 4:30 PM EST
Source: PR Newswire
Importance Score:
8
Price at Filing: $39.99
Real-time Price: $44.80 info
Change: +$4.81 (+12%) info
Market Cap: $1.879B info
AZTA
Oct 30, 2026, 8:02 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $39.87
Real-time Price: $44.80 info
Change: +$4.93 (+12%) info
Market Cap: $1.879B info
AZTA
Oct 07, 2026, 8:01 AM EDT
Filing Type: 8-K
Importance Score:
7
Updated Oct 7, 8:07 AM ET — Azenta expects to recognize the $11M-$13M pre-tax charges in fiscal year ending September 30, 2027 and complete actions by March 31, 2027.
Price at Filing: $40.04
Real-time Price: $44.80 info
Change: +$4.76 (+12%) info
Market Cap: $1.879B info
AZTA
Aug 24, 2026, 8:03 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $36.90
Real-time Price: $44.80 info
Change: +$7.90 (+21%) info
Market Cap: $1.879B info
AZTA
Aug 06, 2026, 4:09 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $30.74
Real-time Price: $44.80 info
Change: +$14.06 (+46%) info
Market Cap: $1.879B info
AZTA
Aug 04, 2026, 4:43 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $30.00
Real-time Price: $44.80 info
Change: +$14.80 (+49%) info
Market Cap: $1.879B info
AZTA
Aug 04, 2026, 4:32 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $30.25
Real-time Price: $44.80 info
Change: +$14.55 (+48%) info
Market Cap: $1.879B info
AZTA
Jul 08, 2026, 8:03 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $24.90
Real-time Price: $44.80 info
Change: +$19.90 (+80%) info
Market Cap: $1.879B info
AZTA
May 08, 2026, 8:11 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $19.10
Real-time Price: $44.80 info
Change: +$25.70 (+135%) info
Market Cap: $1.879B info
AZTA
May 08, 2026, 8:09 AM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $19.10
Real-time Price: $44.80 info
Change: +$25.70 (+135%) info
Market Cap: $1.879B info
AZTA
May 05, 2026, 4:47 PM EDT
Source: Wiseek News
Importance Score:
9
Price at Filing: $23.00
Real-time Price: $44.80 info
Change: +$21.80 (+95%) info
Market Cap: $1.879B info
AZTA
May 05, 2026, 4:42 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $23.00
Real-time Price: $44.80 info
Change: +$21.80 (+95%) info
Market Cap: $1.879B info
AZTA
Apr 07, 2026, 8:30 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $22.45
Real-time Price: $44.80 info
Change: +$22.35 (+100%) info
Market Cap: $1.879B info
AZTA
Apr 07, 2026, 8:15 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $22.31
Real-time Price: $44.80 info
Change: +$22.49 (+101%) info
Market Cap: $1.879B info
AZTA
Apr 02, 2026, 4:13 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $22.63
Real-time Price: $44.80 info
Change: +$22.17 (+98%) info
Market Cap: $1.879B info
AZTA
Apr 02, 2026, 4:10 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $22.63
Real-time Price: $44.80 info
Change: +$22.17 (+98%) info
Market Cap: $1.879B info
AZTA
Mar 04, 2026, 9:15 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $24.80
Real-time Price: $44.80 info
Change: +$20.00 (+81%) info
Market Cap: $1.879B info
AZTA
Mar 04, 2026, 9:11 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $24.80
Real-time Price: $44.80 info
Change: +$20.00 (+81%) info
Market Cap: $1.879B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets